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The transcription factor Osterix (Osx) is required for osteoblast
differentiation and bone formation during embryonic develop-
ment, but it is not known whether Osx has an essential function
in postnatal bone growth and in bone homeostasis. Conditional
deletion of Osx at several time points postnatally revealed that
Osx was essential for osteoblast differentiation and new bone
formation in growing and adult bones. Additionally, inactivation
of Osx in bones severely disrupted the maturation, morphology,
and function of osteocytes. These findings identify Osx as having
an essential role in the cell-specific genetic program of osteocytes.
Interestingly, Osx inactivation also led to the massive accumula-
tion of unresorbed calcified cartilage in a large area below the
growth plate of endochondral bones. This specific area was also
marked by an unanticipated almost complete lack of bone marrow
cells and a marked decrease in the density and size of osteoclasts.
This diminished density of osteoclasts could contribute to the lack
of resorption of mineralized cartilage. In addition, we speculate
that the abnormally accumulated, mainly naked cartilage repre-
sents an unfavorable substrate for osteoclasts. Our study identi-
fies Osx as an essential multifunctional player in postnatal bone
growth and homeostasis.
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The identification of master transcription factors essential forosteoblast differentiation and bone formation during embry-
onic development has greatly advanced our knowledge of bone
biology. However, the transcriptional control of postnatal bone
formation and homeostasis remain poorly understood. Normal
skeletal growth and homeostasis depends on the coordinated
activities of three types of bone cells: osteoblasts, osteoclasts, and
osteocytes. Factors secreted by the mesenchyme-derived osteo-
blasts also control the differentiation and activity of the bone-
resorbing osteoclasts derived from hematopoietic stem cells.
Conversely, bone resorption by osteoclasts releases factors im-
portant for bone formation. Osteocytes, which make up over 90–
95% of all bone cells in adult animals, are derived from mature
osteoblasts and are embedded inside the bone matrix. It has been
suggested that osteocytes are mediators of mechanical and hor-
monal stimulations to control the activity of both osteoblasts and
osteoclasts (1). Osteocytes are regulators of mineralization and
mineral homeostasis (2, 3), and by controlling Sost expression
also act as modulators of Wnt signaling (4).
Three transcription factors [β-catenin, Runx2, andOsterix (Osx)]
are required for osteoblast differentiation and bone formation du-
ring embryonic development (5–9). Osx, which acts downstream
of Runx2, is a zinc-finger-containing transcription factor essential
for embryonic osteoblast differentiation and bone formation (8).
During development, Osx is specifically expressed in osteoblast
lineage cells and, at lower levels, in prehypertrophic chondrocytes,
but not in osteoclasts. Osx-null mutant mice, which die at birth,
develop a complete cartilaginous skeleton, but no bone formation
takes place in either the endochondral ormembranous skeleton. All
skeletal elements of these Osx-null mice are characterized by the
presence of Runx2-expressing precursor cells, which are arrested in
their differentiation and unable to express osteoblast markers.
Recent studies have shown that genetic variants in the region ofOsx
are associated with bone mineral density (BMD) in both children
and adults, suggesting that Osx may continue to play an important
role in the postnatal skeleton (10, 11). However, despite the crucial
role of Osx in osteoblast differentiation and bone formation during
development, an essential role forOsx in postnatal bone growth and
homeostasis has not yet been demonstrated.
To investigate the functions of Osx in skeletal growth and
homeostasis, we conditionally ablated Osx postnatally through
tamoxifen activation of the CreER recombinase (12). Our find-
ings suggest that Osx acts as an essential and central factor of
bone homeostasis after birth, because it is required not only
for new bone formation, osteocyte maturation, and function, but
also for cartilage resorption.
Results
Postnatal Osx Inactivation Leads to Severely Altered Bone Structures.
In the floxed Osx allele, a cassette containing IRES-EGFP pre-
ceded by a LOXP site was inserted 3′ to the poly-A site, whereas
the other LOXP site was in the first intron of the Osx gene. In
mice harboring this allele, EGFP expression occurs only in Osx-
expressing cells when the LoxP sites recombine (13). Immuno-
histochemical (IHC) analyses showed that there were abundant
EGFP-positive cells on the surfaces of trabeculae and cortex in
the humerus of 1-mo-old OsxΔEX2/+ heterozygous mice (Fig. 1A).
Prehypertrophic and hypertrophic chondrocytes were also posi-
tive for EGFP in these mice. This extends previous findings (8)
indicating that Osx continues to be expressed in osteoblasts and
hypertrophic chondrocytes postnatally. In addition, EGFP-posi-
tive cells were seen embedded inside the cortex and trabeculae,
indicating that Osx is expressed in osteocytes as well (Fig. 1A).
Overall expression of Osx is highly specific for osteoblasts,
osteocytes, and (pre)hypertrophic chondrocytes.
To inactivate Osx postnatally, CAG-CreER; Osxfloxed/− mice
were injected with tamoxifen starting at several different time
points after birth. IHC analyses with an anti-EGFP antibody
showed that there were abundant EGFP-positive cells on the
surface of the trabeculae and cortex, as well as embedded inside
the bone matrix (Fig. 1B). Hypertrophic chondrocytes were also
weakly positive for EGFP. This findings confirms that the floxed
Osx allele was efficiently removed in Osx-expressing bone cells
upon tamoxifen injections.
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The Osxpostnatal mutants grew at slower rates than the tamox-
ifen- or vehicle-treated wild-type controls (Fig. S1A). In these
mice, radiography showed the presence of dense mineralized
tissue under the growth plates of all long bones (Fig. S1B).
Microcomputed tomography (μCT) images of the femurs of
Osxpostnatal mutants revealed a number of marked phenotypic
changes. First, there was a zone of intensely mineralized tissue
extending from right beneath the growth plate into the meta-
physis. In contrast, there was a complete absence of trabeculae
below this zone of hypermineralization, and a much thinner
and porous cortical bone. There was also a complete absence of
cortex around and beyond the primary spongiosa (Fig. 1C).
These phenotypes were observed in the P24 Osxpostnatal mutants
10 d after the first tamoxifen injection. The abnormal mineral-
ized tissue progressively increased in size toward the diaphysis of
femurs and also in lumbar vertebrae of Osxpostnatal mutants from
P24 to 3 mo. Also, when Osx was inactivated at 4 mo, and the
mice were killed 3 mo later, the very thin cortical bone showed
multiple microfractures (Fig. S2A). Evidently, postnatal Osx in-
activation led to severely altered bone structures, suggesting that
Osx continues to play a crucial role in the postnatal skeleton.
Osx Is Required for Osteoblast Differentiation and Bone Formation
During and After the Postnatal Growth Period. To examine the role
of Osx in osteoblast differentiation and bone formation during
and after the postnatal growth period, the CAG-CreER;Osxfloxed/−
mice and wild-type controls were injected with tamoxifen or
vehicle starting at weaning or at 4 mo, and then with calcein
shortly before sacrifice at 1.5 mo or 7 mo, respectively. In the
femurs and vertebrae of both tamoxifen- and vehicle-treated
wild-type controls, bone formation was clearly indicated by the
double calcein fluorescent lines lining the cortexes and trabec-
ulae. In contrast, in the Osxpostnatal mutants, there were almost no
intact double or single lines on the surfaces of the trabeculae and
cortex, except a few faint, short, single lines and dots (Fig. 2A
and Fig. S2B). Histomorphometry of lumbar vertebrae of 1.5-
mo-old mice (Table S1) provided further evidence that new bone
formation in Osxpostnatal mutants was dramatically reduced. The
absence of new bone formation was also supported by the greatly
decreased levels of Col1a1 mRNA throughout long bones, as
seen by in situ hybridization (Fig. 2C). Histological analyses
further showed that there were very few morphologically mature
osteoblasts and almost no osteoid on the endosteum in the
Osxpostnatal mutants (Fig. S2C and Fig. 2B). Along with drastically
decreased Osx expression (∼1% of the controls), qPCR meas-
urements of osteoblast-specific marker RNAs, such as Col1a1,
Bsp, and Oc, were all markedly reduced in the Osxpostnatal mu-
tants, despite elevated Runx2 expression and sustained Atf4 ex-
pression (Fig. 2D). Furthermore, primary osteoblast lineage cells
isolated either from calvariae or from the bone marrow mesen-
chymal progenitor cells of the Osxpostnatal mutants completely
failed to form any mineralized nodules in vitro (Fig. 2E). No
difference, however, was seen in the number of bone marrow-
derived CFU fibroblasts (CFU-Fs) between tamoxifen-treated
wild-type and Osxpostnatal mutant mice (Fig. S2D), suggesting
that progenitor cells were not affected. Together, these data
provided solid evidence that Osx is required for osteoblast dif-
ferentiation and bone formation far beyond birth and the initial
growth period.
Fig. 1. Osx expression pattern and skeletal phenotypes of Osxpostnatal mu-
tant mice. (A) anti-eGFP IHC analysis on frozen humerus sections of 1-mo-old
OsxΔEX2/+ mouse. (B) anti-eGFP IHC analysis showed that Osx was effectively
deleted in Osx-expressing cells in the humeri of 2-mo-old Osxpostnatal mutant.
hp, hypertrophic chondrocyte; ob, osteoblast; ocy, osteocyte. (C) μCT images
of the femurs of 2-mo-old mice. Massive accumulation of mineralized tissue
(green dotted circle) and complete absence of trabeculae (green arrow).
For schedules of tamoxifen injections, see Materials and Methods. Wt/Tam,
tamoxifen-treated wild-type mice; Wt/Veh, vehicle-treated wild-type mice;
Null/Tam, tamoxifen-treated Osxpostnatal mutant mice.
Fig. 2. Osx is required for osteoblast differentiation and
bone formation during and after the postnatal growth pe-
riod. (A) Calcein incorporation. The second of two calcein
injections was performed 5 d after the first injection and 2 d
before sacrifice. (B) Goldner staining. (C) Col1a1 in situ hy-
bridization on femur sections of 6-wk-old tamoxifen-treated
control and Osxpostnatal mutant. In A and B, plastic sections
were prepared from 6-wk-old tamoxifen-treated control and
Osxpostnatal mutant. (D) Quantitative PCR analysis of osteo-
blast markers. RNA was isolated from the humeri of P24
tamoxifen-treated mice. (E) In vitro osteogenic assays. (a)
Primary osteoblasts were isolated from the calvariae of P24
tamoxifen-treated Osxpostnatal mutant and control mice.
(b) BMSC was isolated from 2-mo-old tamoxifen-treated
Osxpostnatal mutant and vehicle-injected controls. The cells were
cultured in osteogenic media for 14 d. ARS, alizarin red staining.
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Major Role of Osx in Both Osteocyte Maturation and Function. We
examined the morphology of the Osx-null osteocytes using acid-
etched scanning electronic microscopy (SEM). As shown in Fig.
3A, the osteocytes in the Osxpostnatal mutant were markedly de-
formed. There was a decreased number of osteocytes close to
both periosteum and endosteum in the mutant. Moreover, these
osteocytes were covered with very few dendrites. The number of
dendrites in osteocytes found in the middle of the mutant cortex
was also noticeably decreased, and the overall density of the
dendrite network in the mutant cortex was much reduced. In
addition, the expression levels of Dmp1, Phex, and Sost, which
are highly expressed in normal osteocytes, were significantly re-
duced in the Osxpostnatal mutants (Fig. 3C). Fgf23 expression was
elevated in bones of Osxpostnatal mutants (Fig. S3A) but to a lesser
extent than in Dmp1-null and Hyp mice (2, 3), Serum levels of
both phosphorus and calcium were, however, unchanged (Fig.
S3A). Figure 3B showed that in the Osxpostnatal mutant there were
very few mineral spherical particles in the process of being in-
corporated into the bone matrix, and the bone mineral density
was lower than in the wild-type controls, indicating that the
mineralization process in the Osxpostnatal mutants was seriously
compromised. Furthermore, transmission electron microscopy
(TEM) images revealed that the collagen fibers surrounding
osteocytes in the Osxpostnatal mutant were disorganized, unlike in
the wild-type controls (Fig. S3B).
Moreover, we found that Osx can activate the 2-kb Sost pro-
moter (Fig. S3C) and specifically bind to a DNA fragment lo-
cated within the promoter (Fig. 3D). Mutations in this binding
site that prevented Osx binding inhibited activation of this pro-
moter by Osx. A chromatin immunoprecipitation (ChIP) assay
showed that Osx was able to interact with the same DNA frag-
ment in the chromatin of intact cells (Fig. 3D), indicating that
Sost is a direct target of Osx. Collectively, our findings suggest
that Osx is needed for the maturation and function of osteocytes
postnatally.
We noted that the number of BrdU-positive cells in the primary
spongiosa of the Osxpostnatal mutants was significantly higher than
in the wild-type controls (Fig. S3Da). In contrast, the number of
BrdU-positive cells in proliferating chondrocytes was unchanged
in Osxpostnatal mutants, implying that the function of these cells was
unaffected. The increase in BrdU-positive cells was paralleled by
an increase in Runx2-positive cells, which are likely to be pre-
osteoblasts, in the primary spongiosa of the mutant (Fig. S3Db). It
has been shown that SOST, which is an antagonist of Wnt sig-
naling, was able to inhibit osteoblast proliferation in cell cultures
(14). Given that Osx was highly expressed in osteocytes, and that
loss of Osx led to decreased Sost expression, we speculated that
the increased number of Runx2-positve preosteoblasts might be
linked to the lower levels of Sost expression in osteocytes.
Osx Inactivation Leads to Massive Accumulation of Calcified Cartilage.
Although postnatal Osx inactivation in osteoblast lineage cells
caused the arrest of osteoblast differentiation and bone formation,
we observed a large excess of mineralized tissue in the long bones
of the Osxpostnatalmutants. Both Safranin O and IHC analyses with
antibodies against cartilage-specific matrix proteins (type X col-
lagen and Aggrecan) revealed that the large accumulation of
mineralized tissue in both the lumbar vertebrae (Fig. S4A) and the
femurs (Fig. 4 A and B and Fig. S4B) of the Osxpostnatal mutants
was mainly calcified cartilage matrix.
By in situ hybridization we found no ectopic Col2a1 and
no Col10a1 expression in the zone of excess cartilage of the
Fig. 3. Osx is required for osteocyte maturation and func-
tions. (A) SEM images of the cortexes of humeri of 6-wk-old
mice. (B) Back-scattered SEM images. Arrow, osteocytes; ar-
rowhead, mineral spherical vaterites. (C) Quantitative PCR
analysis of osteocyte markers. RNA was extracted from the
humeri of tamoxifen-treated P24 mice. (D) Sost is a direct
target of Osx. (Upper) EMSA using wild-type, m1, and m2 Sost
oligos. Recombinant Osx was made in baculovirus (23). For
oligo sequences, see Fig. S3C. (Lower) ChIP assay. Chromatin
samples were prepared from BMP-2 treated MC3T3-E1 cells.
Cells were harvested at 0, 15, 30, and 48 h after BMP-2 ad-
dition. The data are presented as percent of input after
subtracting control IgG values.
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Osxpostnatal mutant (Fig. 4C and Fig. S4C). This finding ruled out
the possibility that the abnormal accumulation of cartilage tissue
was produced by Osx-null preosteoblasts.
Mmp13 is expressed by hypertrophic chondrocytes and osteo-
blasts, in whichOsx is also expressed. We reasoned that deletion of
Osx in hypertrophic chondrocytes and osteoblasts may cause re-
ducedMmp13 expression and consequently hinder cartilage ECM
remodeling. Indeed, we found that Mmp13 expression in the long
bones and calvariae and of theOsxpostnatalmutants was significantly
decreased (Fig. S4D). However, IHC analysis with an antibody
that specifically recognizes the MMP-cleaved Aggrecan neopep-
tide revealed that Aggrecan was cleaved in the Osxpostnatal mutants
despite decreasedMmp13 expression, presumably by other MMPs,
such as MMP9, whose expression was unaffected in the Osxpostnatal
mutants (Fig. S4D).
Taken together, our findings suggest that inactivation of Osx
results in the abnormal accumulation of calcified cartilage ma-
trix, which is not caused by ectopic production of cartilage or by
defective cleavage of Aggrecan. Thus, accumulation of miner-
alized cartilage tissue is very likely due to defective resorption.
In theory, tamoxifen administration will activate CAG-CreER
in all cell types, including hematopoietic stem cell-derived osteo-
clasts. RNA analysis of in vitro differentiated osteoclasts indicated
that these cells did not express Osx, suggesting that deletion of
Osx in the cells of this lineage will not affect their osteoclasto-
genic potential in a cell-autonomous manner. Indeed, the mono-
cytes isolated from the bone marrow cells of Osxpostnatal mutants
were able to form tartrate-resistant acid phosphatase (TRAP)-
positive multinucleated osteoclasts as efficiently as the monocytes
from the wild-type controls (Fig. S5A).
The findings in Fig. 4A and Fig. S4A show that while calcified
cartilage was accumulating in the Osxpostnatal mutants, the pre-
existing bone trabeculae were diminishing, as indicated by the
absence of trabeculae right below the zone of calcified cartilages
in the femurs and the markedly reduced trabeculae volume in
the center of the lumbar vertebrae. In addition, the cortical
bones of Osxpostnatal mutants were much thinner and porous.
These results suggested that the resorption defect was more se-
vere in the mineralized cartilage than in the bone matrix. His-
tomorphometry analysis revealed that the density of osteoclasts
in the ectopically accumulated mineralized cartilage was reduced
at least three times in the femurs of Osxpostnatal mutants com-
pared with the same area below the growth plate in control mice
(Fig. 5B). Moreover, the average size of osteoclasts on the sur-
face of this ectopic mineralized cartilage was reduced by about
half compared with that of osteoclasts in control bones (Fig. 5C
and Fig. S5B).
In the cortex, however, the distribution rather than the total
number of osteoclasts was changed. There were many more
osteoclasts inside the thinner and porous cortical bone, but much
fewer in the periosteum of the Osxpostnatal mutants than in control
bones The total number of TRAP-positive osteoclasts in the
cortical bone region was, however, similar in mutants and control
mice (Fig. S5C and Table S2), although the size of the osteoclasts
and the intensity of TRAP staining were reduced in the mutants.
We also noted that the ratio of Opg/Rankl expression in long
bones was higher in the Osxpostnatal mutants than in the wild-type
controls (Fig. S5D). This could account for the overall decrease
in the size of osteoclasts, and the reduced TRAP (Acp5) ex-
pression in the femur of Osxpostnatal mutants (Fig. S5E).
Strikingly, in the area of excess mineralized cartilage in the
femurs of Osxpostnatal mutants, there was an almost complete
absence of bone marrow cells in contrast to the presence of bone
marrow cells in the same area under the growth plate of control
femurs (Fig. 5A and Fig. S5F). There was also an increase in
blood vessels stained by anti-collagen type IV in the area of
mineralized cartilage in Osxpostnatal mutants (Fig. S5F). However,
Fig. 4. Inactivation of Osx led to massive accumulation of calcified cartilage
below the growth plate. (A) von Kossa. (B) Safranin O (SafO) staining. Plastic
sections of femurs of tamoxifen-treated 2-mo-old mice were used for
staining. (C) In situ hybridization of Col2a1 RNA. Decalcified frozen sections
were prepared from the humeri of tamoxifen-treated 6-wk-old mice. gp,
growth plate.
Fig. 5. Absence of bone marrow cells and reduced density of osteoclasts in
the region of ectopic mineralized cartilage. (A) H&E staining showed that in
the zone of mineralized cartilage (marked by the bracket) in the femur of
6-wk-old Osxpostnatal mutant, there are almost no bone marrow cells (red
asterisks). The spaces between the mineralized cartilages are filled by
capillaries (green asterisks). Bone marrow cells are found below the zone of
mineralized cartilage in the mutant. (B) Histomorphometry analysis of
osteoclasts (Oc) in metaphysis (excluding cortex) of femurs of tamoxifen-
treated 2-mo-old control and Osxpostnatal mutants. BS represents mineralized
tissue surface. Tb-1: the area measured from the growth plate to 500 μm
distally; tb-2: the area measured from the end of tb-1 to 500 μm distally; tb-3:
the area measured from the end of tb-2 to 700 μm distally. n = 3/genotype
group. *P < 0.05, **P < 0.001. (C) TRAP staining showed that the size of
osteoclasts found in the Osxpostnatal mutant was much smaller than the ones
in the tamoxifen-treated control mice. Arrows indicate osteoclasts.
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in the marrow cavity of the remainder diaphysis below the zone
of excess cartilage, bone marrow cells were present in apparently
normal amounts. Thus in the endochondral bones of Osxpostnatal
mutant mice, bone marrow cells were largely absent in the area
where accumulation of unresorbed cartilage was found.
Discussion
Our findings indicate that Osx has multiple essential functions in
postnatal bone growth and homeostasis. First, several lines of
evidence show that inactivation of Osx during and after the major
postnatal growth period causes an arrest of osteoblast differen-
tiation and of new bone formation. Our study provides clear ev-
idence that a specific transcription factor essential for embryonic
skeletal development is equally essential for osteoblast differen-
tiation and new bone formation postnatally.
To study the Osx postnatal functions, we inactivated Osx after
birth using CAG-CreER, a ubiquitously expressed rather than
osteoblast-specific Cre recombinase. Inactivation of Osx by a ubiq-
uitously expressed recombinase allowed us to explore the potential
function of Osx in cells of the osteoblast lineage before expression
of osteoblast-specific marker genes A recent study showed that
mice, in which the conditional allele of Osx was inactivated by
using a Cre transgene driven by a osteoblast-specific Col1a1 pro-
moter (15), developed a much milder phenotype compared with
the Osxpostnatal mutant mice described here. Unlike our Osxpostnatal
mutant mice, in which osteoblast differentiation and bone forma-
tion was completely arrested, these mice exhibited only a moder-
ately decreased osteoblast activity. One major difference between
these two conditional mice models is that in the Col1a1-Cre mo-
del, Osx was ablated only in differentiated Col1a1-expressing
osteoblasts, whereas in the CAG-CreER model, Osx was deleted in
all cell types, including cells involved in all stages of osteoblast
differentiation. Another difference is that in the Osx flox/−;Col1a1-
Cre mice, inactivation of Osx began around E14.5 when the oste-
oblast-specific Col1a1 promoter became active, in contrast to the
Osxpostnatal mutants described here. A subsequent study that used
a Col1a1-CreERT2 transgene to delete Osx postnatally produced
only a modest decrease in bone formation and bone mineral density
(16). No osteocyte anomalies and no abnormal cartilage accumula-
tion were described in either of these two studies; furthermore,
the number and function of osteoclasts was also unchanged. The
phenotype of the Osxflox/−;Col1a1-Cre mice indicated that Osx was
needed for the optimal function of Col1a1-expressing osteoblasts,
whereas the present mouse model demonstrated that Osx was
not only essential for osteoblast differentiation and bone forma-
tion in postnatal mice, but also for cartilage resorption and osteo-
cyte maturation and function.
During bone formation, osteoblasts first deposit an unminer-
alized bone matrix called osteoid, which mainly consists of type I
collagen. The osteoid subsequently becomes mineralized by in-
corporation of small mineralized particles. This mineralization
process is believed to be principally regulated by osteocytes (1).
In the present mouse model, the abnormal Osx-null osteocytes
could be derived from either existing osteocytes or Osx-null
osteoblasts, which already had begun to express Col1a1 (15) at
the time of tamoxifen injections. The fact that some of the ab-
normal osteocytes in Osxpostnatal mutants were surrounded by
unorganized collagen fibers (Fig. S3B) suggested that some ab-
normal osteocytes might be derived from Osx-null mature
osteoblasts. This finding suggested that Osx plays a key role in
the maturation of osteocytes. Other lines of evidence support the
notion that Osx is also required for osteocyte maintenance and
functions. The defective mineralization process in the Osxpostnatal
mutants was likely due to the combined decreased expression of
Dmp1 and Phex, not to hypophosphatemia, because the blood
phosphate levels were normal. Furthermore, the finding that Osx
interacted with a specific site in the sclerostin promoter both in
EMSA experiments and in intact cells, and activated this pro-
moter in transfection assays, suggested that Osx is also a player in
mature osteocytes. Preliminary results showed that inactivation
of Osx by Dmp1-Cre, which is highly expressed in osteocytes
postnatally, led to morphological osteocyte abnormalities similar
to those in Osxpostnatal mutants. Overall, our findings identify Osx
as a critical transcription factor required for the maturation and
function of osteocytes.
The endochondral bones of Osxpostnatal mutants were also
characterized by a massive accumulation of calcified cartilage,
which during the growth period extended progressively more
deeply toward the diaphysis. This process was driven by the
continuous activity of growth plate-proliferating chondrocytes.
The unique characteristic of these mice was that the growth plate
chondrocytes continued their activity, but no new bone was being
formed. The zone of excess cartilage did not contain Col2a1-
or Col10a1-expressing cells, or active osteoblasts, as indicated
by the virtual absence of Col1a1-expressing cells. This zone did
contain cells in which the Osx promoter was active, as illustrated
by EGFP positivity and also an abundance of Runx2-positive
cells. Our findings clearly indicate that cartilage resorption is
severely defective in Osxpostnatal mutants. It is unlikely that this
lack of resorption would be due to a selective increase in OPG
production by hypertrophic chondrocytes, because OPG immu-
nohistochemistry did not show a significant increase in staining in
the hypertrophic zone of Osxpostnatal mutant mice (Fig. S5G).
Therefore, we suggest that the process of cartilage resorption is
tightly coupled to Osx-dependent bone formation.
In osteopetrotic bones, cartilage and bone tissues accumulate
and completely fill the marrow cavity (17). This suggests that
osteoclasts are the cells that resorb both cartilage and bone
matrices. In Osxpostnatal mutant endochondral bones the overall
number of osteoclasts and their size, as well as TRAP expression,
was reduced. The reduction in osteoclast numbers was especially
marked in the zone of excessive accumulated cartilage. Despite
the overall reduction in TRAP expression and activity, our find-
ings suggested that osteoclasts were functional in bone resorp-
tion. Indeed, the intrinsic ability of precusor cells from Osxpostnatal
mutants to differentiate into osteoclasts in culture was very similar
to that of control cells. In addition, the presence of numerous
osteoclasts inside the thin and porous cortical bones, and the
gradual disappearance of preexisting bone trabeculae once Osx
was ablated, strongly supported this view.
During the normal process of endochondral bone formation
in the primary spongiosa, osteoblasts first use the cartilage as
a scaffold to deposit a bone-specific matrix. During bone re-
modeling, αvβ3 integrin, which is expressed at high levels in
osteoclasts, has a major role in the attachment of osteoclasts to
this bone matrix and their subsequent function. αvβ3 integrin
interacts with several bone matrix proteins, including bone sia-
loprotein (BSP), which is expressed at especially high levels in the
primary spongiosa. Both loss- and gain-of-function mouse gene-
tic experiments strongly support a role for Bsp in bone resorption
(18, 19). Expression of Bsp and several other ECM components
was markedly reduced in Osxpostnatal-null bones. The existence of
an essentially naked cartilage scaffold not covered by bone was
a unique abnormality in Osxpostnatal-null endochondral bones. We
propose that the absence of bone formation on the surface of
the cartilage scaffold and the reduced number and size of osteo-
clasts in the area of excess mineralized cartilage could account
for the defective resorption of this cartilage.
The reduction in the overall number and size of osteoclasts
and in TRAP expression in Osxpostnatal-null long bones could be
attributed to an increase in the ratio of Opg to Rankl expression,
which itself was a likely consequence of the observed decrease in
Sost expression.
One other potential mechanism that might also have accounted
for the failure of cartilage resorption is much less likely. We found
that the expression of Mmp13 in the femurs and calvariae of
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the Osxpostnatal mutant mice was significantly reduced (20, 21).
Nevertheless, despite decreased Mmp13 expression, the specific
cleavage of Aggrecan by MMPs in the Osxpostnatal mutant mice
took place.
In Osxpostnatal-null mutants—specifically in the region of ec-
topic mineralized cartilage—we observed a clear correlation
between the lack of new bone and the absence of bone marrow
cells. These data suggested that in the primary spongiosa, Osx-
dependent endochondral bone formation was required for the
formation of bone marrow cells. Our findings are in agreement
with a recent study that grafted endochondral bone progenitor
cells under the kidney capsule (22). In this assay, these cells had
an essential role in the generation of host-derived bone marrow
and knockdown of Osx in these progenitor cells, which inhibited
donor-derived osteogenesis and abolished formation of the he-
matopoietic stem cell niche and bone marrow cells in the host
(22). Our findings represent the in vivo skeletal equivalent of the
graft study. We speculate that the absence of mature osteoblasts
and the lack of bone in the zone of ectopic mineralized cartilage
causes the localized absence of bone marrow cells.
The Osxpostnatal-null mutant mice grew slower than wild-type
controls. The moderate expansion of the hypertrophic zone of
these mice could be due to reduced expression of Mmp13. Be-
cause the blood levels of phosphate were normal in Osxpostnatal-
null mice, the slower growth and the expanded hypertrophic
zone cannot be due to hypophosphatemia, as is the case in
Dmp1-null mice. We propose that the decreased growth of
Osxpostnatal-null limbs could be accounted for by the increase in
size of the hypertrophic zone, lack of new bone formation, and
the accumulation of unresorbed mineralized cartilage.
In summary, our findings suggest that postnatally, Osx has an
essential role in osteoblast differentiation and bone formation.
Osx is also needed for the maturation and full expression of the
genetic program and hence the function of osteocytes after birth.
Furthermore, our data strongly suggest that cartilage resorption
is coupled to Osx-dependent endochondral bone formation. The
lack of resorption of the accumulated unresorbed mineralized
cartilage under the growth plate in the Osxpostnatal mutants could
be accounted for in part by the decrease in osteoclast function
and density in this area and by the inefficiency of osteoclasts to
resorb cartilage in absence of bone deposition on the surface of
the cartilage scaffold. Our study thus identifies Osx as an in-
dispensable multifunctional actor in postnatal skeletal growth
and homeostasis.
Materials and Methods
Generation of Osxpostnatal Mutant Mice. The OsxΔEX2/+ mice were generated by
crossing Osxfloxed/floxed and Prm-Cre mice. CAG-CreER transgenic mice (12)
were purchased from Jackson Laboratory. The tamoxifen-treated CAG-
CreER;Osxfloxed/− mice are referred to throughout the text as Osxpostnatal
mutant mice; the vehicle or tamoxifen-treated CAG-CreER;Osxfloxed/+ mice
are referred to as wild-type controls. Mice were injected intraperitoneally
with tamoxifen 1.5–3.0 mg/10 g body weight (Sigma-Aldrich) or vehicle (corn
oil containing 10% ethanol) at the desired postnatal days. Osxpostnatal mu-
tant mice and wild-type controls were injected three times with either ta-
moxifen or vehicle from P15 to P20 and killed at P24; four times (twice with
3 mg/10 g body weight and twice with 1.5 mg/10 g body weight) from P16
to P26 and killed at 6 wk; or four times (3 mg/10 g body weight) from P21
to P30 and killed at 2 mo. These mice are designated P24, 6 wk, and 2 mo.
X-ray, μCT, and Histomorphometry Analyses. See SI Materials and Methods
for the following procedures: RNA isolation and quantitative PCR anal-
yses; EMSA and transfection; in vitro osteoclastogenesis and in vitro osteo-
blastogenesis; immunohistochemical analysis and in situ hybridization; EM
analysis of osteocytes; chromatin immunoprecipitation (ChIP) assay; and
statistical analyses.
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